Skip To Main Content
Uchenna Simon Ezenkwa on Muck Rack

Uchenna Simon Ezenkwa

As seen in: eCancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Uchenna Simon

Contact Uchenna Simon, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Low prostaglandin-endoperoxide synthase-2 gene expression in colorectal carcinomas may predict poorer survival

|
By Uchenna Simon Ezenkwa, Oluwadamilare Iyapo, Sebastian Anebuokhae Omenai, Chinedu Anthony Ezekekwu
| eCancer Verified
Uchenna Simon Ezenkwa, Sebastian Anebuokhae Omenai, Oluwadamilare Iyapo, Chinedu Anthony Ezekekwu, Adesoji E Adetona, Chima Uzoma Akunwata, Ayotunde Oladunmi Ale, Henry Okwuchukwu Ebili Introduction: Prostaglandin-endoperoxide synthase-2 (ptgs2), otherwise called Cyclooxygenase 2, is overexpressed in colorectal carcinoma (CRC) compared to normal tissues. however, the impact of differential expression among ptgs2-positive tumours on CRC prognosis has not been well investigated.
Open in Who Shared Issue with article?

EpCAM expression negatively regulates E-cadherin function in colorectal carcinomas

|
By Uchenna Simon Ezenkwa, Gabriel Olabiyi Ogun, Mbwas Isaac Mashor, Olufemi John Ogunbiyi
| eCancer Verified
Category Sub-category Article type Volume Abstract | Full Article | PDF Research Background: This study aimed to characterise epithelial cell adhesion molecule (EpCAM) expression patterns in colorectal carcinomas (CRC) from Nigerian patients, its association with E-cadherin and tumour characteristics, to forecast patient selection for anti-EpCAM therapy among whom no data existed previously.
Open in Who Shared Issue with article?

Cancer histotypes and trends in Azare, Northeast Nigeria: impact of diagnostic support disparity in data reporting

|
By Uchenna Simon Ezenkwa, Mohammed Imam, Maimuna Orahachi Yusuf, Abdullahi Sani Giade
| eCancer Verified
Background: Definitive, affordable, and timely diagnosis of cancer is key to providing data for surveillance and control programmes. Care disparities have been shown to contribute to poorer survival, especially in resource-constrained populations. Here, we describe the profile of histologically diagnosed cancers in our hospital and highlight the possible effects of inadequate diagnostic support on data reporting.
Open in Who Shared Issue with article?
See all 6 articles